CLX
October 30, 2024 - AI Summary
Undervalued by 171.9% based on the discounted cash flow analysis.
Market cap | $14.46 Billion |
---|---|
Enterprise Value | $17.17 Billion |
Dividend Yield | $4.90 (4.15%) |
Earnings per Share | $6.56 |
Beta | 0.49 |
Outstanding Shares | 123,173,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 17.97 |
---|---|
PEG | 33.47 |
Price to Sales | 2.23 |
Price to Book Ratio | 42.34 |
Enterprise Value to Revenue | 2.42 |
Enterprise Value to EBIT | 10.53 |
Enterprise Value to Net Income | 21 |
Total Debt to Enterprise | 0.17 |
Debt to Equity | 8.97 |
No data
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...